0.01Open0.01Pre Close0 Volume3.37K Open Interest27.00Strike Price0.00Turnover4852.80%IV24.27%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0071Delta0.0048Gamma3564.00Leverage Ratio-17.3557Theta0.0000Rho-25.44Eff Leverage0.0000Vega
JD.com Stock Discussion
• Nasdaq Composite
While the index continued to face downward pressure, it managed to hold above the key 20,000level, which remains a critical support. The market's focus is now on whether this level can hold in the coming days. If it does, we could see a short-term recovery, but failure to hold this support could signal a deeper correction towards the 19,500 area.
• S&P 500
The market remains indecisive...
The U.S. stock market, in its second bullish year, repeatedly shattered records. Nvidia claimed the crown, tech giants reigned supreme, and AI continued to fuel the market's ascent. Globally, interest rates took a downturn amidst ongoing g...
• Nasdaq Composite
The Nasdaq dipped slightly by 0.32% to close at 20,109.06, maintaining its position above the critical 20,000 level. This aligns with yesterday's observation that the index is undergoing a healthy consolidation phase. The resilience above this psychological threshold continues to signal steady demand, though momentum appears to be slowing. Further observatio...
• Nasdaq Composite
The Nasdaq jumped 1.24% to close at 20,173.89, marking another record high after gapping up at the open. Tech bulls remain dominant, but the key level to watch going forward is 20,000—whether it sustains or breaks could dictate the next leg. Short-term pullbacks are possible given the sharp rise, but tech remains the market’s driving force.
• S&P 500
The S&P 500 edged up 0...
total position has come to a nett loss of 35k mainly due to my holdings in $GENM (4715.MY)$ which constitutes almost 66% of my portfolio.
A series of bad news that engulfed $GENM (4715.MY)$ for the past year: fire that broke out in the indoor theme park, the lawsuit by its partner in USA and the subsequent disqualification from the bursa klci 30 has hammered down genm price and that really hurts ...
loading...
No comment yet